Chongqing Kangning v. Conrex Pharmaceutical Corp.

CourtSuperior Court of Pennsylvania
DecidedApril 19, 2021
Docket939 EDA 2020
StatusUnpublished

This text of Chongqing Kangning v. Conrex Pharmaceutical Corp. (Chongqing Kangning v. Conrex Pharmaceutical Corp.) is published on Counsel Stack Legal Research, covering Superior Court of Pennsylvania primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Chongqing Kangning v. Conrex Pharmaceutical Corp., (Pa. Ct. App. 2021).

Opinion

J-A23017-20

NON-PRECEDENTIAL DECISION - SEE SUPERIOR COURT I.O.P. 65.37

CHONGQING KANGNING : IN THE SUPERIOR COURT OF BIOENGINEERING CO., LTD : PENNSYLVANIA : Appellant : : : v. : : : No. 939 EDA 2020 CONREX PHARMACEUTICAL CORP :

Appeal from the Order Entered February 20, 2020 In the Court of Common Pleas of Chester County Civil Division at No(s): No. 2019-08925-CT

BEFORE: KUNSELMAN, J., NICHOLS, J., and PELLEGRINI, J.*

MEMORANDUM BY NICHOLS, J.: FILED: APRIL 19, 2021

Appellant Chongquing Kangning Bioengineering Co., Ltd., appeals from

the order overruling its preliminary objections, which requested arbitration on

the counterclaims filed by Appellee Conrex Pharmaceutical Corp.1 Appellant

contends that the trial court erred by not recognizing that the two agreements

at issue are related but separate independent agreements and by holding that

____________________________________________

* Retired Senior Judge assigned to the Superior Court. 1 “An order overruling preliminary objections is an interlocutory order. The law is clear, however, that an order overruling preliminary objections that seek to compel arbitration is an interlocutory order appealable as of right pursuant to 42 Pa.C.S. § 7320(a)(1) and Pa.R.A.P. 311(a)(8).” In re Estate of Atkinson, 231 A.3d 891, 897-98 (Pa. Super. 2020). “Because this case was decided on preliminary objections, we rely on the facts as alleged in the complaint, including its exhibits.” Khawaja v. RE/MAX Central, 151 A.3d 626, 627 n.1 (Pa. Super. 2016) (citation omitted). We may cite to the parties’ reproduced record for their convenience. J-A23017-20

Appellant waived its right to arbitration. Appellant concedes in its brief that

the agreements are related, but argues that as a matter of law that the

agreements are treated as separate. We agree and reverse.

We state the facts as pled in Appellant’s complaint. Appellant is a

Chinese corporation, and Appellee is a Pennsylvania corporation. R.R. at 1a.

On October 18, 2012, the parties executed a contract (October 2012 contract)

in which Appellant was the exclusive agent of Appellee’s skincare products in

China. Id. at 2a. The October 2012 contract contains a mandatory arbitration

clause, which states in relevant part that “the parties shall resolve any dispute

arising from this contract through negotiation. If no agreement can be

reached, [the parties] both agree” to arbitration. Id. at 58a (formatting

altered).

Per the October 2012 contract, Appellant paid Appellee $599,985.00 “for

products and services and also advances for future products and services.”

Id. at 2a. Appellee delivered goods and services worth around $354,811.13.

Id. Appellant contends that after costs and other expenses, Appellee still

owes Appellant at least $243,192.41. Id.

In a November 16, 2018 letter (2018 confirmation letter) signed by the

parties, they agreed that Appellee owed Appellant $243,192.41:

[Appellant] and [Appellee] executed the [October 2012 contract]. [Appellant’s] financial records show we made a number of payments totaling $599,985.00 US dollars for the ordered goods pursuant to the above Agreement and [Appellee] has delivered goods and charged for the associated costs, which total $345,811.13 US dollars, as of October 12, 2018.

-2- J-A23017-20

Our President Wang Qiong and your President Phyllis Hsieh hereby agree on the following accounts after their audit of the delivery of goods and the transfer of funds: . . . .

Id. at 79a. Attached to the letter were tables and exhibits listing financial

transactions, which essentially showed that Appellee owed Appellant

$243,192.41. See, e.g., id. at 91a.

On March 6, 2019, Appellee sent a letter to Appellant to terminate the

October 2012 contract. Id. at 3a. Appellant countered that Appellee could

not unilaterally terminate the October 2012 contract, but was willing to end

the business relationship as long as Appellee repaid Appellant the amount still

owed. Id.

Appellee failed to repay, however, which resulted in Appellant filling the

instant complaint on September 4, 2019, against Appellee. Id. at 1a.

Appellant sued Appellee for breach of the 2018 confirmation letter, unjust

enrichment, conversion, and account stated. Id. at 1a-5a. Appellant

requested damages in the amount owed of $243,192.41, plus interest, costs,

and expenses. Id. at 5a.

On October 9, 2019, Appellee filed an answer, new matter, and

counterclaims. Id. at 12a. Specifically, Appellee filed counterclaims for

breach of the October 2012 contract and for unfair competition. Id. at 19a-

20a. On December 4, 2019, Appellant filed preliminary objections, which

contended that Appellee’s counterclaims based on the October 2012 contract

were subject to that contract’s mandatory arbitration clause. Id. at 36a, 40a.

-3- J-A23017-20

On February 20, 2020, the trial court overruled Appellant’s preliminary

objections and ordered Appellant to file an answer to Appellee’s counterclaims.

Order, 2/20/20. In relevant part, the trial court concisely held that the “two

alleged contracts are intertwined.” Id. at n.1.2 The trial court further held

that Appellant, “[b]y initiating the instant action for breach of the [2018

confirmation letter] which would not exist without the [October 2012 contract,

Appellant] has waived its right to demand arbitration on [Appellee’s]

counterclaims.” Id.; accord Trial Ct. Op., 4/29/20, at 2-3.

On March 20, 2020, Appellant filed a timely notice of appeal.3 Appellant

timely filed a court-ordered Pa.R.A.P. 1925(b) statement.

Appellant raises the following issue on appeal:

1. Did the trial court err as a matter of law by failing to recognize that the 2018 confirmation letter—an agreement with no arbitration provision—is separate and distinct from the [October 2012 contract]?

2. Did the trial court err as a matter of law in finding [Appellant] intentionally waived the mandatory arbitration provision in the [October 2012 contract] when [Appellant] only asserted claims arising from a 2018 confirmation letter containing no such provision, and [Appellant] used its first opportunity to seek dismissal of counterclaims that are properly adjudicated through binding arbitration?

2The trial court cited no legal authorities in support of its holding or otherwise explained its legal reasoning on this point. 3 Meanwhile, on March 5, 2020, Appellant filed a motion for reconsideration. On March 25, 2020, the trial court dismissed Appellant’s motion for reconsideration as moot due to the pending appeal. Order, 3/25/20.

-4- J-A23017-20

Appellant’s Brief at 5 (formatting altered).

In support of its first issue, Appellant argues that the 2018 confirmation

letter is an agreement separate from the October 2012 contract. Id. at 13.

In Appellant’s view, those two agreements are separate because there was no

integration clause in the 2018 confirmation letter incorporating the October

2012 contract. Id. at 13-14. Appellant notes that the October 2012 contract

“deals with the parties establishing their relationship six years [prior to the

2018 confirmation letter] and addresses events that might happen in the

future, such as trademark usage, product purchasing, and ownership of goods

outlined therein” and was made under circumstances different than the 2018

confirmation letter. Id. at 15. Appellant contends that because the 2018

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Small v. Small
137 A.2d 870 (Superior Court of Pennsylvania, 1958)
Neville v. Scott
127 A.2d 755 (Superior Court of Pennsylvania, 1956)
O'DONNELL v. Hovnanian Enterprises, Inc.
29 A.3d 1183 (Superior Court of Pennsylvania, 2011)
Fell, R. v. 340 Associates, LLC
125 A.3d 75 (Superior Court of Pennsylvania, 2015)
David v. Veitscher Magnesitwerke Actien Gesellschaft
35 A.2d 346 (Supreme Court of Pennsylvania, 1943)
Donahue v. Philadelphia
41 A.2d 879 (Superior Court of Pennsylvania, 1944)
Wilson v. Viking Corp.
3 A.2d 180 (Superior Court of Pennsylvania, 1938)
Khawaja, H. v. Re/Max Central
151 A.3d 626 (Superior Court of Pennsylvania, 2016)
Nicholas, J. v. Hofmann, D.
158 A.3d 675 (Superior Court of Pennsylvania, 2017)
Maxatawny Township v. Kutztown Borough
113 A.3d 895 (Commonwealth Court of Pennsylvania, 2015)
Leinbach v. Wolle
61 A. 248 (Supreme Court of Pennsylvania, 1905)
International Milling Co. v. Hachmeister, Inc.
110 A.2d 186 (Supreme Court of Pennsylvania, 1955)
Richburg v. Palisades Collection LLC
247 F.R.D. 457 (E.D. Pennsylvania, 2008)
In Re:Est. of Atkinson, J., Appeal of: Wells Fargo
2020 Pa. Super. 87 (Superior Court of Pennsylvania, 2020)

Cite This Page — Counsel Stack

Bluebook (online)
Chongqing Kangning v. Conrex Pharmaceutical Corp., Counsel Stack Legal Research, https://law.counselstack.com/opinion/chongqing-kangning-v-conrex-pharmaceutical-corp-pasuperct-2021.